Company Filing History:

6 out of 40

Mirus Bio Corporation

Years Active: 2002-2011

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8021875 - Methods for expression of transgenes (2011-09-20),

2. 7803782 - Intravenous delivery of polynucleotides to cells in mammalian limb (2010-09-28),

3. 7781415 - Process for delivering sirna to cardiac muscle tissue (2010-08-24),

4. 7601367 - Compositions and processes using siRNA, amphipathic compounds and polycations (2009-10-13),

5. 7589059 - Delivery of molecules and complexes to mammalian cells in vivo (2009-09-15),

6. 7473419 - Intravascular delivery of nucleic acid (2009-01-06),

7. 7262056 - Enhancing intermolecular integration of nucleic acids using integrator complexes (2007-08-28),

8. 7192605 - Nucleic acid transfer complexes (2007-03-20),

9. 7101995 - Compositions and processes using siRNA, amphipathic compounds and polycations (2006-09-05),

10. 7015040 - Intravascular delivery of nucleic acid (2006-03-21),

11. 6867196 - Process for delivering nucleic acids to cardiac tissue (2005-03-15),

12. 6458382 - Nucleic acid transfer complexes (2002-10-01),

Title: The Innovative Contributions of Inventor Hans Herweijer

Introduction

Hans Herweijer, an accomplished inventor based in Madison, WI, has made significant contributions to the field of biotechnology, holding a total of 12 patents. His work has had a considerable impact on the methods utilized in gene expression and delivery systems for genetic material.

Latest Patents

Among his latest patents, one focuses on "Methods for expression of transgenes," which involves compositions and methods designed to enhance long-term expression both in vitro and in vivo. This invention notably comprises sequences and gene expression cassettes that improve the expression of the targeted genes. Another notable patent involves "Intravenous delivery of polynucleotides to cells in mammalian limb." This method allows for the effective delivery of polynucleotides by injecting them into a distal vein of a limb that is temporarily occluded, facilitating the extravasation of the solution into the surrounding tissue.

Career Highlights

Throughout his career, Hans has worked for prominent companies such as Mirus Bio Corporation and Roche Madison Inc. His experience in these organizations has considerably refined his expertise and contributed to his innovation capabilities in the realm of biotechnology.

Collaborations

Hans has collaborated with various talented individuals in his field, including Jon Asher Wolff and James E Hagstrom. These collaborations have undoubtedly enriched his work and fostered the exchange of innovative ideas among like-minded professionals.

Conclusion

Hans Herweijer is a testament to the impact that dedicated inventors can have on advancing technology in biotechnology. Through his substantial patent portfolio, he continues to influence the way genetic engineering and polynucleotide delivery are approached. His work is vital for the ongoing development of innovative techniques that hold promise for future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com